Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 29, 2009


Alnylam Pharmaceuticals has promoted Akshay Vaishnaw to the position of senior vice president of clinical research.

Vaishnaw previously served as Alnylam’s vice president of clinical research.

Pfizer has named Cathy Pachuk as senior director of delivery technology at its Research Technology Center, which focuses on, among other things, the company’s RNAi therapeutics efforts.

The company has also appointed C. Satishchandran as chief technology officer of the RTC.

Both Pachuk and Satishchandran were co-founders of Nucleonics, a now-defunct developer of expressed RNAi-based drugs. The company was shut down last year amid legal wrangling between the co-founders and senior management (see RNAi News, 11/6/2008).

Dicerna Pharmaceuticals has appointed Ronald Kahn to its scientific advisory board.

Kahn is currently a senior investigator at the Joslin Diabetes Center, where he heads the Joslin Section on Obesity and Hormone Action. He is also a professor of medicine at Harvard Medical School, according to Dicerna.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.